Keywords: scios, arthritis, drug, enters, phase, recently-completed, trial

Scios arthritis drug enters Phase I

Article | 25 January 2001

Print This

A recently-completed Phase I trial of SCIO-469, Scios' novel oral p38kinase inhibitor, indicates that the drug is well-tolerated in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in